Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.8300 (-2.1%) ($103.4200 - $103.8300) on Mon. Dec. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 76 | Latest Price | $103.8300(-2.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND advances 7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(51%) IWC(50%) | Factors Impacting LGND price | LGND will decline at least -1.43% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $103.68(0.14%) | 10 Day Moving Average | $101.46(2.34%) | 20 Day Moving Average | $94.76(9.57%) | To recent high | -2.1% | To recent low | 29.2% | Market Cap | $1.669b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |